News and Announcements
Ideapod Capital Raise Closing Soon
- Published July 27, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Ideapod is an innovative communication platform helping people to learn and connect around ideas. We are experiencing rapid growth, with over 2.2 million monthly active users (up from 450,000 in April) and increasing our revenue each month.
- Ideapod is a global communication platform helping people to learn and connect around ideas;
- The company has almost fully allocated a convertible note, raising US$ 1.5 million with US$ 9 million cap and/or 20% discount converting to preferred shares at series A (targeting valuation of $20-30 million). The company is cash flow positive;
- The platform is experiencing rapid growth, reaching 3.6 million monthly active users (up from 450,000 in April);
- Current investors include 37 Angels, Dragon Tree Capital, Andy Tobias (treasurer of the Democratic National Party) and Dr. Alan Dupont.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
